(Virtual) Summer Undergraduate Research Symposium
Friday, July 30, 2021
10:00 a.m. - 3:00 p.m.
The 2021 (Virtual) Summer Undergraduate Research Symposium celebrates undergraduate research in the Greater Pittsburgh area, offering an exciting opportunity for student researchers, science faculty, and area professionals to interact and share in undergraduate research.
Abstract submission guidelines:
Abstracts must conform to the following format:
Font: Arial 10 point
Length: Maximum of 150 words (not including titles and names)
Title of Written Abstract (in bold)
Authors (Last name, First name)
Text of Abstract (150 words)
10:00 a.m. - Keynote Address by Dr. Shon Remich, VP Global Head of Clinical and Operations, Takeda Pharmaceuticals
11:00 a.m. - Breakout Session I.
12:00 p.m. - Lunch (On Your Own).
1:00 p.m. - Breakout Session II.
2:00 p.m. - Ice Cream Social and Sendoff, on Mellon Hall patio, Bluff Side
Shon A. Remich, M.D.
Senior Director, Vaccine Clinical Research and Development, Pfizer
The title of Dr. Shon Remich's talk is "The SARS-CoV2 Pandemic: Perspectives from a Vaccine Developer"
ABOUT DR. REMICH
Dr. Remich received his medical degree from the University of Oklahoma where he conducted his first honors
research and was awarded a Health Education Scholarship (HPSP) from the United States Army. After completing
his Pediatric internship and residency, he served as Chief of Pediatrics at Reynolds Army Hospital. His formal
training in research began with a post-doctorate in Clinical Pharmacology at Georgetown University joining Dr.
David Flockhart's pharmacogenetics lab. In 2001, Dr. Remich joined the Walter Reed Army Institute of Research
(WRAIR) and was deployed to Kenya to establish the military's first dedicated drug development platform at the
US Army Medical Directorate-Africa (USAMRD-A) and conducted the first GMP IV Artesunate study on the
continent. Leveraging the success of life saving treatments, Dr. Remich developed a passion for playing a role in
the prevention as well as the treatment of devastating neglected diseases, culminating in a second post-doctorate
in Allergy and Immunology at the joint National Institutes of Health and Walter Reed Medical Center program. In
2008, he returned to Kenya to lead the Department of Defense ‘s Presidential Emergency Plan for Aids Relief
(PEPFAR) country program and as the military liaison to the Kenyan Defense Forces HIV prevention program. He
was selected by the US ambassador to Kenya to lead select public health initiatives augmenting PEPFAR's
improvement in infant survival and health care infrastructure. Returning to the US in 2012, he became the Senior
Director of WRAIR's Translational Medicine division, conducting clinical trials in Malaria, Dengue, Shigella,
Anthrax, Chikungunya, as well as the first study of the VSV-Ebola vaccine with additional duties included
overseeing the operations and major expansion of WRAIR's multiple campaign Pilot Bioproduction Facility.
Following his 23 year military career, he joined Pfizer's vaccine clinical research and development team executing
pivotal phase 3 studies for C difficile, overseeing the expansion and US licensure of Tico-Vax (tick born encephalitis
vaccine), and assuming a pivotal role in the development of the Pfizer-BioNTech mRNA COVID vaccine. In 2021,
Dr. Remich joined Takeda Pharmaceuticals to lead their clinical development and operational Vaccine branch
including vaccine candidates for Dengue, Zika, Norovirus, COVID, and influenza.
Watch Dr. Remich's Keynote Address
For more information about the Summer Research Symposium, take a look at materials from prior symposia.